Cargando…
Interleukin-1 Stimulates β-Cell Necrosis and Release of the Immunological Adjuvant HMGB1
BACKGROUND: There are at least two phases of β-cell death during the development of autoimmune diabetes: an initiation event that results in the release of β-cell-specific antigens, and a second, antigen-driven event in which β-cell death is mediated by the actions of T lymphocytes. In this report,...
Autores principales: | Steer, Sarah A, Scarim, Anna L, Chambers, Kari T, Corbett, John A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1316065/ https://www.ncbi.nlm.nih.gov/pubmed/16354107 http://dx.doi.org/10.1371/journal.pmed.0030017 |
Ejemplares similares
-
The mechanism of HMGB1 secretion and release
por: Chen, Ruochan, et al.
Publicado: (2022) -
Regulation of HMGB1 Release in Health and Diseases
por: Wang, Haichao
Publicado: (2022) -
HMGB1 released from nociceptors mediates inflammation
por: Yang, Huan, et al.
Publicado: (2021) -
Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology
por: Kwak, Man Sup, et al.
Publicado: (2020) -
Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial Endotoxin
por: Ferrari, Davide, et al.
Publicado: (1997)